Wide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein array

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1761, Issue 9, 2006, Pages 1014-1021

  Benítez, Sònia ^a   Camacho, Mercedes ^a   Bancells, Cristina ^a   Vila, Luis ^a   Sánchez Quesada, José Luis ^a   Ordóñez Llanos, Jordi ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Electronegative LDL; Granulocyte monocyte colony stimulating factor; GRO; Inflammation; Interleukin 6

Indexed keywords

AUTACOID; CHEMOKINE; CYTOKINE; FATTY ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE A2;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCUBATION TIME; LIPOLYSIS; MEDIATOR RELEASE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MICROARRAY; SUPERNATANT; UMBILICAL VEIN;

CELLS, CULTURED; CHEMOKINES, CXC; CYTOKINES; ENDOTHELIAL CELLS; FATTY ACIDS, NONESTERIFIED; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; INTERLEUKIN-6; LIPOPROTEINS, LDL; PHOSPHOLIPASES A; PROTEIN ARRAY ANALYSIS; UMBILICAL VEINS;

EID: 33748444617     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2006.03.020     Document Type: Article

References (37)

1. Avogaro P., Bittolo-Bon G., and Cazzolato G. Presence of a modified low density lipoprotein in humans. Arteriosclerosis 8 (1988) 79-87
2. Shimano H., Yamada N., Ishibashi S., Mokuno H., Mori N., Gotoda T., Harada K., Akamura Y., Murasa T., Yazaki Y., and Takaku F. Oxidation-labile subfraction of human plasma low-density lipoprotein isolated by ion-exchange chromatography. J. Lipid Res. 32 (1991) 763-773
3. Nyyssönen K., Kaikkonen J., and Salonen J.T. Characterization and determinants of an electronegatively-charged low-density lipoprotein in human plasma. Scand. J. Clin. Lab. Invest. 56 (1996) 681-689
4. Sánchez-Quesada J.L., Otal-Entraigas C., Franco M., Jorba O., González-Sastre F., Blanco-Vaca F., and Ordóñez-Llanos J. Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with familial hypercholesterolemia. Am. J. Cardiol. 84 (1999) 655-659
5. Sánchez-Quesada J.L., Pérez A., Caixàs A., Rigla M., Payés A., Benítez S., and Ordóñez-Llanos J. Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: nonenzymatic glycosylation and oxidative modifications. J. Clin. Endocrinol. Metab. 86 (2001) 3243-3249
6. Sánchez-Quesada J.L., Benítez S., and Ordóñez-Llanos J. Electronegative low-density lipoprotein. Curr. Opin. Lipidol. 15 (2004) 329-335
7. de Castellarnau C., Sánchez-Quesada J.L., Benítez S., Caveda L., Rosa R., Vila L., and Ordóñez-Llanos J. Electronegative LDL from normolipemic subjects induces IL-8 and monocyte chemotactic protein secretion by human endothelial cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2281-2287
8. Sánchez-Quesada J.L., Camacho M., Antón R., Benítez S., Vila L., and Ordóñez-Llanos J. Electronegative LDL of FH subjects. Chemical characterization and induction of chemokine release from human endothelial cells. Atherosclerosis 166 (2003) 261-270
9. Ziouzenkova O., Asatryan L., Sahady D., Orasanu G., Perrey S., Cutak B., Hassell T., Akiyama T.E., Berger J.P., Sevanian A., and Plutzky J. Dual roles for lipolysis and oxidation in peroxisome proliferation-activator receptor responses to electronegative low density lipoprotein. J. Biol. Chem. 278 (2003) 39874-39881
10. Demuth K., Myara I., Chappey B., Vedie B., Pech-Ansellem M.A., Haberland M.E., and Moatti N. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 773-783
11. Chang Y.H., Abdalla D.S.P., and Sevanian A. Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein. Free Radical Biol. Med. 23 (1997) 202-214
12. Chen C.H., Jiang T., Yang J.H., Jiang W., Lu J., Marathe G., Pownall H.J., Ballantyne C.M., McIntyre T.M., Henry P.D., and Yang C.Y. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 107 (2003) 2102-2108
13. Benítez S., Camacho M., Arcelus R., Vila L., Bancells C., Ordóñez-Llanos J., and Sánchez-Quesada J.L. Increased lysophosphatidylcholine and non-esterified fatty acid content in LDL induces chemokine release in endothelial cells. Relationship with electronegative LDL. Atherosclerosis 177 (2004) 299-305
14. Benítez D., Villegas V., Bancells C., Jorba O., González-Sastre F., Ordóñez-Llanos J., and Sánchez-Quesada J.L. Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to non-esterified fatty acids and lysophosphatidylcoline content. Biochemistry 43 (2004) 15863-15872
15. Stephan Z.F., and Yurachek E.C. Rapid fluorimetric assay of LDL receptor activity by DiI labeled LDL. J. Lipid Res. 34 (1993) 325-330
16. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18 (2000) 217-242
17. Rott D., Zhu J., Zhou Y.F., Burnett M.S., Zalles-Ganley A., and Epstein S.E. IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new paradigm for infection-induced atherogenesis. Atherosclerosis 170 (2003) 223-228
18. Viedt C., Vogel J., Athanasiou T., Shen W., Orth S.R., Kübler W., and Kreuzer J. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kB and activator protein-1. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 914-920
19. Cowburn A.S., Deighton J., Walmsley S.R., and Chilvers E.R. The survival effect of TNF-alpha in human neutrophils is mediated via NF-kappa B-dependent IL-8 release. Eur. J. Immunol. 34 (2004) 1733-1743
20. Geiser T., Dewald B., Ehrengruber M.U., Clark-Lewis I., and Baggiolini M. The interleukin-8-related chemotactic cytokines GROα, GROβ and GROγ activate human neutrophil and basophil leukocytes. J. Biol. Chem. 268 (1993) 15419-15424
21. Gersten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone Jr. M.A., Luster A.D., Luscinskas F.W., and Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
22. Gomez-Cambronero J., Horn J., Paul C.C., and Baumann M.A. Granulocyte-macrophage colony-stimulating factor is a chemoattractant cytokine for human neutrophils: involvement of the ribosomal p70 S6 kinase signaling pathway. J. Immunol. 171 (2003) 6846-6855
23. Yang C.Y., Raya J.L., Chen H.H., Chen C.H., Abe Y., Pownall H.J., Taylor A.A., and Smith C.V. Isolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1083-1090
24. Sakai M., Kobori S., Miyazaki A., and Horiuchi S. Macrophage proliferation in atherosclerosis. Curr. Opin. Lipidol. 11 (2000) 503-509
25. Plenz G., Reichenberg S., Koenig C., Rauterberg J., Deng M.C., Baba H.A., and Robenek H. Granulocyte-macrophage colony-stimulating factor modulates the expression of type VIII collagen mRNA in vascular smooth muscle cells and both are codistributed during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1658-1668
26. Savenkova M.I., Mueller D.M., and Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low-density lipoprotein. J. Biol. Chem. 269 (1994) 20394-20400
27. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., and Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol. 158 (2001) 879-891
28. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107 (2003) 363-369
29. Ridker P.M., Rifai N., Stampfer M.J., and Hennekens C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (2000) 1767-1772
30. Parissis J.T., Venetsanou K.F., Kalantzi M.V., Mentzikof D.D., and Karas S.M. Serum profiles of granulocyte-macrophage colony-stimulating factor and C-C chemokines in hypertensive patients with or without significant hyperlipidemia. Am. J. Cardiol. 85 (2000) 777-779
31. Rezaie-Majd A., Maca T., Bucek R.A., Valent P., Müller M.R., Husslein P., Kashanipour A., Minar E., and Baghestanian M. Simvastatin reduces expression of cytokines interleukin-6, interleukin-8 and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1194-1199
32. Zozulinska D., Majchrzak A., Sobieska M., Wiktorowitz K., and Wierusz-Wysocka B. Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42 (1999) 117-118
33. Straczkowski M., Dzienis-Straczkowska S., Stepien A., Kowalska I., Szelachowska M., and Kinalska I. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J. Clin. Endocrinol. Metab. 87 (2002) 4602-4606
34. Sánchez-Quesada J.L., Pérez A., Caixàs A., Ordóñez-Llanos J., Carreras G., González-Sastre F., and de Leiva A. Electronegative low-density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control. Diabetologia 39 (1996) 1469-1476
35. Sánchez-Quesada J.L., Benítez S., Franco M., Otal C., Blanco-Vaca F., and Ordóñez-Llanos J. Density distribution of electronegative LDL (LDL(-)) in normolipemic and hyperlipemic subjects. J. Lipid Res. 43 (2002) 699-705
36. Benítez S., Ordóñez-Llanos J., Franco M., Marín C., Paz E., López-Miranda J., Otal C., Pérez-Jiménez F., and Sánchez-Quesada J.L. Effect of simvastatin in familial hypercholesterolemia on the affinity of charge-differing low-density lipoprotein subfractions to the low-density lipoprotein receptor. Am. J. Cardiol. 93 (2004) 414-420
37. Benítez S., Sánchez-Quesada J.L., Ribas V., Jorba O., Blanco-Vaca F., González-Sastre F., and Ordóñez-Llanos J. Platelet-activating factor acetylhydrolase (PAF-AH) is mainly associated with electronegative low-density lipoprotein subfraction. Circulation 108 (2003) 92-96